Escherichia species

Optimal result: 3.7 – 3800 x10^4 CFU/g

Elevated levels of Enterococcus species in a gastrointestinal (GI) test can be a sign of various medical conditions, reflecting their complex role in human health. Enterococcus, particularly Enterococcus faecalis and Enterococcus faecium, are part of the normal gut flora but can become problematic when their growth surpasses normal levels. This overgrowth can be triggered by a range of factors, including antibiotic use, which disrupts the balance of gut microbiota, allowing enterococci to proliferate. Another cause could be a compromised immune system, where the body's natural defenses are weakened, making it more susceptible to infections by these otherwise commensal bacteria.

Symptoms associated with an overgrowth of Enterococcus in the GI tract can vary but often include abdominal pain, bloating, irregular bowel movements, and in more severe cases, symptoms of infection such as fever, nausea, and vomiting. In cases where Enterococcus species enter the bloodstream or other sterile body sites, they can cause serious infections like endocarditis, urinary tract infections, and bacteremia, especially in hospitalized patients or those with underlying health conditions.

The treatment for elevated Enterococcus levels largely depends on the specific circumstances and severity of the condition. In cases where symptoms are mild and no serious infection is present, restoring the balance of gut flora might be the focus. This can involve dietary changes, probiotics, and sometimes withdrawing or altering antibiotic therapy that may have contributed to the imbalance. However, in cases where an infection is present, especially with strains resistant to common antibiotics like Vancomycin-Resistant Enterococcus (VRE), treatment becomes more challenging. Such infections require targeted antibiotic therapy, guided by susceptibility testing to determine the most effective drugs. Infections caused by VRE may require the use of less commonly used antibiotics such as linezolid or daptomycin. Moreover, supportive care to manage symptoms and prevent complications is also crucial in treatment. It's important to note that handling Enterococcus overgrowth or infection requires a personalized approach, considering factors like the patient's overall health, the presence of other medical conditions, and the specific strain of Enterococcus involved.

Enterococcus species, commonly detected in gastrointestinal (GI) tests, represent a significant group of bacteria naturally inhabiting the human gut. These species, particularly Enterococcus faecalis and Enterococcus faecium, are noteworthy for their dual nature: while being normal constituents of the intestinal microbiota, they can also act as opportunistic pathogens. Their presence in GI tests can sometimes be indicative of a healthy, balanced gut flora, but their overgrowth or presence in certain clinical contexts can signal an imbalance or an infection.

Enterococcus species, commonly detected in gastrointestinal (GI) tests, represent a significant group of bacteria naturally inhabiting the human gut. These species, particularly Enterococcus faecalis and Enterococcus faecium, are noteworthy for their dual nature: while being normal constituents of the intestinal microbiota, they can also act as opportunistic pathogens. Their presence in GI tests can sometimes be indicative of a healthy, balanced gut flora, but their overgrowth or presence in certain clinical contexts can signal an imbalance or an infection. Enterococci are known for their resilience, having the ability to survive harsh conditions, which also makes them a concern in healthcare settings due to their resistance to many antibiotics. This resistance complicates treatment of infections caused by these bacteria, such as urinary tract infections, bacteremia, and endocarditis. Furthermore, Enterococcus species are often used as indicators of fecal contamination in water and food, reflecting their ubiquity in the environment. In GI testing, the detection and quantification of Enterococcus can provide crucial information for diagnosing infections or assessing the microbial balance in the gut. However, interpreting these results requires careful consideration of the patient’s clinical history and symptoms, as the mere presence of Enterococcus species does not unequivocally indicate disease. Advances in molecular biology and microbiology have enhanced the detection and characterization of these bacteria, contributing to a better understanding of their role in health and disease.

Escherichia species
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Escherichia species — 10,000+ markers explained
One Escherichia species result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro